211 related articles for article (PubMed ID: 9393550)
1. Soft-tissue sarcoma involving bone or neurovascular structures: MR imaging prognostic factors.
Panicek DM; Go SD; Healey JH; Leung DH; Brennan MF; Lewis JJ
Radiology; 1997 Dec; 205(3):871-5. PubMed ID: 9393550
[TBL] [Abstract][Full Text] [Related]
2. Local Staging of Soft-Tissue Sarcoma: Emphasis on Assessment of Neurovascular Encasement-Value of MR Imaging in 174 Confirmed Cases.
Holzapfel K; Regler J; Baum T; Rechl H; Specht K; Haller B; von Eisenhart-Rothe R; Gradinger R; Rummeny EJ; Woertler K
Radiology; 2015 May; 275(2):501-9. PubMed ID: 25584707
[TBL] [Abstract][Full Text] [Related]
3. Osseous invasion by soft-tissue sarcoma: assessment with MR imaging.
Elias DA; White LM; Simpson DJ; Kandel RA; Tomlinson G; Bell RS; Wunder JS
Radiology; 2003 Oct; 229(1):145-52. PubMed ID: 14519874
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
5. Assessment of vascular invasion by musculoskeletal tumors of the limbs: use of contrast-enhanced MR angiography.
Feydy A; Anract P; Tomeno B; Chevrot A; Drapé JL
Radiology; 2006 Feb; 238(2):611-21. PubMed ID: 16436820
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
7. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Bredella MA; Caputo GR; Steinbach LS
AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
[TBL] [Abstract][Full Text] [Related]
8. Bone invasion in extremity soft-tissue sarcoma: impact on disease outcomes.
Ferguson PC; Griffin AM; O'Sullivan B; Catton CN; Davis AM; Murji A; Bell RS; Wunder JS
Cancer; 2006 Jun; 106(12):2692-700. PubMed ID: 16700041
[TBL] [Abstract][Full Text] [Related]
9. Periosteal margin in soft-tissue sarcoma.
Lin PP; Pino ED; Normand AN; Deavers MT; Cannon CP; Ballo MT; Pisters PW; Pollock RE; Lewis VO; Zagars GK; Yasko AW
Cancer; 2007 Feb; 109(3):598-602. PubMed ID: 17183556
[TBL] [Abstract][Full Text] [Related]
10. Results of surgery and multimodal therapy for patients with soft tissue sarcoma invading to vascular structures.
Hohenberger P; Allenberg JR; Schlag PM; Reichardt P
Cancer; 1999 Jan; 85(2):396-408. PubMed ID: 10023708
[TBL] [Abstract][Full Text] [Related]
11. MR imaging of malignant soft-tissue tumors.
Hanna SL; Fletcher BD
Magn Reson Imaging Clin N Am; 1995 Nov; 3(4):629-50. PubMed ID: 8564687
[TBL] [Abstract][Full Text] [Related]
12. [Surgical aspects in the multidisciplinary treatment of soft tissue sarcomas].
Röhrborn A; Röher HD
Praxis (Bern 1994); 1998 Aug; 87(34):1050-60. PubMed ID: 9757788
[TBL] [Abstract][Full Text] [Related]
13. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity].
Li Y; Niu XH; Xu HR
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):964-9. PubMed ID: 22333413
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognosis of stage IV alveolar soft part sarcoma].
Zhao J; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):932-6. PubMed ID: 23336381
[TBL] [Abstract][Full Text] [Related]
16. The role of magnetic resonance imaging. When to use it and what to look for.
McKenzie AF
Acta Orthop Scand Suppl; 1997 Feb; 273():21-4. PubMed ID: 9057583
[TBL] [Abstract][Full Text] [Related]
17. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
19. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339
[TBL] [Abstract][Full Text] [Related]
20. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
